Kiora Pharmaceuticals, Inc.
KPRX
$2.10
$0.2111.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 26.80K | -2.15M | -2.19M | -4.22M | -3.41M |
| Total Depreciation and Amortization | 38.20K | 31.50K | 19.60K | 17.40K | 14.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.43M | 390.10K | 399.90K | -149.60K | 1.02M |
| Change in Net Operating Assets | 87.00K | -2.07M | -930.70K | 2.10M | 3.30M |
| Cash from Operations | -1.27M | -3.80M | -2.70M | -2.25M | 920.10K |
| Capital Expenditure | -400.00 | -32.20K | -- | 45.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.74M | 696.40K | 2.67M | 437.70K | -1.92M |
| Cash from Investing | 5.74M | 664.20K | 2.67M | 482.70K | -1.92M |
| Total Debt Issued | 1.75M | 1.00M | -- | -- | -- |
| Total Debt Repaid | -1.75M | -1.00M | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 265.40K | -- | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 0.00 | 265.40K | -- | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | 13.20K | 131.60K | 10.10K | -75.50K | 62.30K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -- | -- | -- |
| Net Change in Cash | 4.48M | -2.74M | -21.30K | -1.85M | -938.00K |